Osteopenia and enhanced risk fracture often accompany Type I diabetes. 3 However, the association between Type 2 diabetes and bone mass has been ambiguous 4 with reports of enhanced, reduced, or similar BMDs compared to healthy individuals. 5
INTRODUCTION 1
The occurrence of osteoporosis in diabetic individuals has been recognized since 2 the beginning of the twentieth century (Albright & Reifenstein 1948 , Berney 1952 , 3 Morrison et al. 1927 . However, the observed rates of osteoporosis reported in insulin-4 dependent Type 1 diabetes mellitus differ from those reported in non-insulin-dependent 5 Type 2 diabetes. While the association between osteoporosis and Type 1 diabetes is well 6 established (Forst et al. 1995 , Silberberg 1986 , the reported association between 7 osteoporosis and Type 2 diabetes is less clear. The literature documents bone mineral 8 densities (BMDs) of Type 2 diabetes patients that are diminished (Isaia et al. 1987) , 9 enhanced (Van Daele et al. 1995) , or similar (Wakasugi et al. 1993 ) to those of non-10 diabetic control subjects. However, reports of enhanced BMDs in Type 2 diabetes 11 individuals are often confounded by increased rates of obesity in these patients, as obesity 12 is positively associated with increased bone mass (Dalen et al. 1975) . For example, 13 reduced BMD has been reported in Type 2 diabetic men while no bone loss occurred in 14 obese Type 2 diabetic women (Buysschaert et al. 1992) . Investigators have also recently 15
shown Type 2 diabetes to be associated with an increased risk of fracture (e.g., hip, 16 proximal humerus, and foot) in older adults (Forsen et al. 1999 , Keegan et al. 2002 , 17 Meyer et al. 1993 , Nicodemus & Folsom 2001 , Ottenbacher et al. 2002 , Schwartz et al. 18 2001 . In the study of osteoporotic fractures, BMD of older diabetic women was higher 19 than control subjects, yet their relative risk for non-spinal fractures increased (Schwartz 20 et al. 2001) . Given the ambiguity in the human literature of the effects of Type 2 21 diabetes on BMD (Isaia et al. 1987 , Van Daele et al. 1995 , Wakasugi et al. 1993 , and 22 the possible disassociation between BMD and fracture risk (Schwartz et al. 2001) , the 23 Page 3 of 35 slope of the linear portion of the curve, the energy absorbed (in N-mm) was determined 1 as the area under the curve to ultimate load, and the post-yield displacement (in mm) was 2 the displacement from yield to fracture. Material properties were estimated by 3 normalizing structural properties to bone geometry at the site of testing using the 4 following equations from classical beam theory: elastic modulus (in GPa) = K x S 3 / (48 5
x CSMI x 1,000); ultimate stress (in MPa) = UL x S x (D / 2) / (4 x CSMI), where CSMI 6 is the mid-diaphysis cross-sectional moment of inertia (in mm 4 ), D the midshaft bone 7 diameter (in mm), and S the support span distance (in mm). CSMI values were averaged 8 from three pQCT slices and were taken about the anatomic axis of bending, which was 9 the ML axis for femora and the AP axis for tibiae. D was measured by calipers in the 10 direction of loading (i.e., AP for femora and ML for tibae). 11
Mechanical tests were also conducted on the femoral neck, a site of mixed cortical 12 and cancellous bone. The proximal half of the femur was placed in a rigid (aluminum) 13 fixture containing machined holes of various sizes. Specimens were inserted such that 14 they were tightly seated up to the lesser trochanter and oriented with the main axis of the 15 femoral shaft vertical. Quasi-static loading was applied to the femoral head in a direction 16 parallel to the femoral shaft (vertical) at a displacement rate of 2.5 mm/min (0.1 in/min) 17 until complete fracture. Load-displacement data were collected and analyzed similar to 18 the procedures described above for three-point bending, except only structural properties 19 (ultimate load and stiffness) are applicable in this case. 20
Statistical Analysis: Two-way ANOVA was used to compare differences among 21 ZDF rats and their respective age-matched lean controls, with Student-Neuman-Keuls 22 post-hoc tests applied when a significant F was achieved. Alpha levels of p 0.05 were 23 considered statistically significant and group differences of p < 0.10 are acknowledged. 1 Data are represented as means ± S.E. 2 3
RESULTS

4
Body mass was higher in the ZDF rats vs. their lean age-matched controls at 7 and 5 13 weeks of age (Table 1) . However, body mass in the long-term diabetic rats (20 wks) 6 was similar to lean controls. Blood glucose levels were not different between groups in 7 the pre-diabetic condition, but were higher with short-and long-term Type 2 diabetes 8 (Table 1) . Hyperinsulinemia occurred during the pre-and short-term diabetic states (i.e., 9 7 and 13 wks) in the ZDF rats (Table 1) . Lengths of femora and tibiae were smaller in 10 ZDF rats at all age groups, suggesting a small deficit in longitudinal growth even when 11 total body weight was greater in the pre-and short-term diabetic conditions (Table 2) . 12
Bone Mineral Density and Geometry 13
Appendicular mid-shaft bone (femur and tibia): Cross-sectional moments of 14 inertia (CSMI) were the same (both femora and tibiae) in pre-diabetic animals versus lean 15 controls, but lower with the progression of the disease (short-term diabetes, for tibiae) or 16 with long-term Type 2 diabetes (both femora and tibiae) ( Figure 1A and 1C) , Similarly, 17 despite a higher cortical BMD in tibia in pre-diabetic animals, this measure of bone mass 18 was lower with short-and long-term Type 2 diabetes in both the femur and tibia ( Figure  19 1B and 1D). 20
Mixed cortical and cancellous bone (distal femur metaphysis, proximal tibial 21
metaphysis, and femoral neck): Total BMD (including cortical shell and cancellous core) 22 and cancellous BMD were assessed at three sites having mixed cortical and cancellous 23 bone ( Figure 2 ). Pre-diabetic rats had increased cancellous BMD at the distal femur 1 (+9%) and total BMD at the proximal tibia (+10%) vs. lean controls. However, this 2 enhancement disappeared or was reversed by 13 wks in the short-term diabetic condition. 3
With long-term diabetes at 20 wks, deficits in total and cancellous BMD occurred relative 4
to lean controls at all three bone sites, ranging from a minimum of 6% deficit in 5 cancellous BMD at the femoral neck to a 29% reduction in cancellous BMD at the distal 6 femur. 7
Axial bone (L3 and L4 vertebrae) : Volumetric BMD of L3 vertebral body in the 8 7 wk ZDF rats was 10% lower than that in lean controls; however, the difference in BMD 9 narrowed by 20 wks of age ( Figure 3A ). When bone mineral content of the entire L4 10 vertebra was assessed with ashing, no differences were observed in pre-and short-term 11 diabetes stages. At 20 wks, the long-term diabetic ZDF rats exhibited a significantly 12 lower ash weight in comparison to lean controls ( Figure 3B ). The L4 vertebrae were 13 visually smaller at 20 wks in the ZDF rats ( Figure 3C ), consistent with the reduced ash 14 weights in this group. 15
Structural and Material Properties 16
Appendicular mid-shaft bone (tibia and femur): Three-point bending to failure 17 tests assessed mechanical properties of mid-shaft cortical bone (Table 2 ). Deficits in 18 stiffness appeared in the femur and tibia in the short-term diabetic (13 wk old) ZDF rats 19 (-17% and -14.5%, respectively) , as compared to lean controls at the same age. These 20 deficits in stiffness were exacerbated in long-term diabetic rats (-23% and -18%, 21 respectively). Ultimate load, the maximal force absorbed by the bone, was 11% lower in 22 the tibia in short-term diabetic rats but not in the femur. By 20 wks of age, this deficit 23 (vs. lean controls) doubled for the tibia (-22%) and became apparent in the femur as well 1 (-19%) . These alterations are illustrated with idealized load-displacement curves 2 utilizing yield, ultimate load and fracture data points in Figure 4 . 3 Toughness of mid-shaft bone, defined as energy absorbed to ultimate load 4 (estimated by area under the load displacement curve up to displacement at ultimate load) 5 is reduced significantly in long-term diabetes by 23% and 26% in femora and tibiae, 6
respectively. Post-yield displacement, an indicator of bone ductility, was not different 7 between ZDF and lean rats in the femur. Large variability in the tibia likely prevented 8 post-yield displacement from achieving statistical significance in short-term (-31% vs 9 lean controls) and long-term diabetes (-51% vs lean controls). Data for material 10 properties, which describe mechanical properties of the bone tissue independent of its 11 size or geometry, revealed that only elastic modulus of the femur was reduced by 19% 12 and 25% in pre-diabetic and short-term diabetic ZDF rats, respectively. 13
Mixed cortical and cancellous bone (femoral neck):
Compressive loading of the 14 femoral necks (which also involves bending and shear forces) was performed to assess 15 mechanical properties at this site. Ultimate load was reduced 18% in the short-term ZDF 16 rats vs. lean controls and 44% in long-term diabetic animals ( Figure 5 ). Stiffness of the 17 femoral neck was slightly higher in short-term diabetic rats at 13 wks (+16%), but with 18 the progression of long-term diabetes stiffness was reduced (34%) versus that of the age-19 matched lean controls. 20 Currently there are conflicting reports in the literature regarding the effects of 2 Type 2 diabetes on BMD in humans (Isaia et al. 1987 , Van Daele et al. 1995 , Wakasugi 3 et al. 1993 , as well as an apparent dissociation between BMD and fracture risk in Type 2 4 diabetic patients (Schwartz et al. 2001) . These apparent discrepancies could be the result 5 of the type of bone studied (e.g., cancellous vs. cortical) or the severity and duration of 6 the disorder in the subject population studied. In addition, co-existing obesity in most 7
Type 2 diabetic humans confounds interpretation. Therefore, the purpose of the present 8 study was to determine whether Type 2 diabetes alters bone structural and mechanical 9 properties in the ZDF rat and to determine whether possible declines in BMD and bone 10 mechanical properties coincide with the onset and progression of the disease. To our 11 knowledge, this is the first investigation to examine the combined alterations in the 12 structural and mechanical properties of the ZDF skeleton with the onset and progression 13 of Type 2 diabetes. The results demonstrate that in the prediabetic condition, which is 14 associated with normoglycemia and hyperinsulinemia, there is an increase in tibial BMD 15 (Fig 1 & 2) . In contrast, the short-and long-term diabetic conditions, which are 16 associated with fasting hyperglycemia, predisposes femora and tibiae to diminished 17
BMDs and mechanical integrity (Table 2, Figures 1, 2, and 5). 18
Longitudinal growth was impaired in both femora and tibiae as early as 7 wks of 19 age in pre-diabetes, preceding the development of hyperglycemia. By 20 wks of age, 20 these long bones were 7-8% shorter than bones of age-matched lean controls. 21
Interestingly, the increase in long bone diameters and cross-sectional moments of inertia 22 (CSMI) observed in Goto-Kakizaki rats, another rodent model of Type 2 diabetes 23 (Ahmad, 2003), was not observed in the ZDF rats. In fact, data from the present study 1 provide evidence for reduced radial growth as illustrated by smaller CSMI values in the 2 long-term diabetic (20 wk old) rats. Lower ash weights of the L4 vertebral bodies of 3 ZDF rats in the present investigation suggest that this effect on longitudinal and/or radial 4 growth impacts on the axial skeleton as well. 5
The significant reduction in cross-sectional geometry of the long bones is likely 6 the major contributor to the reductions observed in the mechanical properties (ultimate 7 load and stiffness) of the short-and long-term diabetic rats. The estimated bending 8 strength of the humeral and tibial diaphyses in Goto-Kakizaki rats has been reported to be 9 higher relative to Wistar control animals (Ahmad et al. 2003 ). The present study offers 10 a more complete determination of bone strength changes with Type 2 diabetes, with 11 direct measurement of mechanical properties during three stages of development and 12 progression of Type 2 diabetes. It is unknown whether the different results of Ahmad et 13 al. (23) from 12-month-old Goto-Kakizaki rats are in part related to the severity and 14 duration of the disease, or to key differences in this rodent model of Type 2 diabetes with 15 that of the ZDF rat. 16
Deficits in mid-shaft cortical BMD were also observed in long bones, but were 17 relatively smaller than those in CSMI. For the significant differences in CSMI 18 highlighted in Fig 1A and 1C , percent reductions range from 15% to 30%, whereas the 19 significant differences in BMD (Fig 1B and 1D ) are all less than 5%. One might expect 20 alterations in BMD to impact more directly on material properties, since density is 21 independent of bone size, but elastic modulus of the femur was the only material 22
property affected by Type 2 diabetes (and only at 7 and 13 wks). No significant 23 differences were observed for ultimate stress, which is the tissue-level strength. In one 1 way, these results suggest a decoupling, or disassociation, between tissue mineralization 2 and material properties. On the other hand, the percent differences in BMD are quite 3 small, although statistically significant, yet material properties are generally not 4 significantly different. To further explore this, correlations were determined between 5 material properties (elastic modulus, ultimate stress) and BMD. When all age groups 6 were included (pooling lean and fatty animals), r 2 values ranged from 0.35 to 0.67 due 7 mainly to the significantly lower values for the 7-wk animals. Correlation r 2 values 8 dropped to less than 0.15 when only the short-and long-term diabetic groups were 9 included, further suggesting a disassociation. 10
Considering this disassociation, and even the different effects for the two long 11 bones studies, suggests a major role for other determinants of bone functional properties 12 (beyond cross-sectional geometry and BMD). The possibilities include the quality of the 13 mineral, the bonding between mineral and collagen, and the properties of the organic 14 matrix. One key candidate in this last category would be the accumulation of advanced 15 glycation end-products (AGEs) as has been observed with chronic hyperglycemia in 16 another rodent model for Type 2 diabetes, the WBN/Kob rat (Saito et al., 2006) . It is also 17 interesting to note that energy absorbed to ultimate load, an indicator of bone toughness, 18 was decreased by 24-26% in the tibiae and femora of long-term diabetic rats. This 19 property is determined by both the structural properties of stiffness and ultimate load, but 20 also by bone ductility, which may be reduced in the long-term diabetic rats, as indicated 21 by numerical reductions in post-yield displacement. 22
Much of the published literature assessing BMD changes in diabetics utilizes dual 1 energy x-ray absorptiometry, which cannot distinguish independent effects on cortical 2 and cancellous bone. Utilizing computed tomography, the present study revealed more 3 dramatic effects on cancellous bone compartments in appendicular bone with short-term 4 (13 wks) and long-term progression (20 wks) of Type 2 diabetes, particularly at the 5 proximal tibia and distal femur. Axial bone may respond differently, since the deficit 6 observed in L3 vertebral cancellous BMD in the pre-diabetic (7 wk that cancellous bone volume (determined histologically) in the distal femur and vertebral 11 bodies was diminished when symptoms of diabetes were manifested for 1, 2, and 7-8 12 months. Cortical thickness of the femur and vertebra were not different at any time 13 between the Cohen diabetic and control rats (Amir et al. 2002) . CT data from ZDF rats 14 of the present study suggests that the cortical shell is slightly diminished, since total 15 BMD (assessing cortical shell plus cancellous core) at all 3 metaphyseal sites was 16 affected to a similar degree as the cancellous BMD. 17
Collectively, data from the present study support the hypothesis that Type 2 18 diabetes adversely affects bone structural and mechanical properties of the ZDF rat, and 19 that the severity of these changes increases with the temporal progression of the disease. 20
The ZDF strain is a diabetic rat model (Charles River Laboratories) and was chosen for 21 study because it allows for the examination of skeletal properties during the development 22 of Type 2 diabetes separate from those induced by obesity, which can have profound 23 effects on bone structural and mechanical properties. Further, the onset and progression 1 of Type 2 diabetes has been well characterized in this strain and allows for the 2 determination of bone properties with corresponding changes in insulin resistance, 3 impaired glucose tolerance and intolerance, and hyperglycemia, all of which can 4 influence skeletal tissue (Clark et al. 1983 , Peterson et al. 1990b , Sparks et al. 1998 ). In 5 contrast, the Goto Kakizaki rat is a strain that develops moderate Type 2 diabetes 6 (Janssen et al. 2004) , and alterations in bone mechanical and structural properties in the 7 most common mouse strain used for Type 2 diabetes research, the db/db mouse (Wu & 8 Huan 2007 ) , have been previously characterized (Ealey et al., 2006) . 9
Further, the results of the current investigation suggest that disparities in the 10 human literature regarding the effects of Type 2 diabetes on skeletal properties may be 11 associated with the bone sites studied and the severity or duration of the disease in the 12 patient population studied. In addition to the greater fragility of bone associated with the 13 progression of Type 2 diabetes, the present study also demonstrates that some important 14 effects (e.g., on longitudinal growth) may occur in the pre-diabetic hyperinsulinemic and 15 euglycemic condition. 16
Several mechanisms may be involved in the observed alterations in bone 17 structural and mechanical properties. These mechanisms include the effects of 1) 18 hyperinsulinemia, 2) hyperglycemia, and 3) leptin on skeletal tissue, as well as 4) the 19 effects of hyperglycemia on the bone vascular system and corresponding alterations in 20 bone and marrow perfusion. 21
Hyperinsulinemia and Skeletal Tissue. Circulating insulin alters the metabolism 22 and promotes growth of many target tissues, including the skeletal system. In fact, insulin 23 stimulates osteoblastic activity (Canalis et al. 1977 , Raisz & Kream 1983 , resulting in 1 enhanced bone formation. Consistent with this effect, BMDs in ZDF rats of the present 2 study were greater in the distal femora (Fig 2B) , proximal tibiae ( Fig 2C) and tibial mid-3 shafts (Fig 1D) in the pre-diabetic state (7 wks) when plasma insulin concentration was 4 correspondingly higher. Regression analysis further indicated there was a significant 5 linear relation between changing plasma insulin concentrations and femoral BMD in the 6 ZDF rat (Fig 6A) . The relation between BMD and insulin levels has also been reported 7 in human Type 2 diabetics, where BMD was positively correlated with fasting serum 8 insulin concentrations (Rishaug et al. 1995) . Further, increased BMDs at various skeletal 9 sites have been reported in hyperinsulinemic individuals in the presence and absence of 10 Type 2 diabetes (Verhaege et al. 1996) . Taken together, these studies suggest that 11 hyperinsulinemia contributes to increased BMD in both humans and rodents. 12
Hyperglycemia and Skeletal Tissue. The chronic hyperglycemia manifested in 13
Type 2 diabetes accelerates the non-enzymatic process of protein glycosylation, resulting 14 in the formation and accumulation of AGEs. AGEs accumulate in bone with age (Fratzl 15 et al. 2004 , Miyata et al. 1996 , Odetti et al. 2005 and have been suggested to contribute 16 to skeletal fragility (Bailey et al. 1998 , Dominguez et al. 2005 , Schwartz 2003 . AGEs were not assessed in the present study, previous work has documented increased 3 skeletal AGEs and reduced bone strength in diabetic rats (Katayama et al. 1996 , Tomasek 4 et al. 1994 . AGEs accumulation could also negatively influence bone through direct 5 effects on osteoblasts (Katayama et al. 1996) and/or osteoclasts (Fong et al. 1993) . For 6 example, the accumulation of AGEs on bone matrix reduces bone formation rates and 7 increases calcium efflux from calvariae, exacerbating bone resorption (Fong et al. 1993) . 8
In the present study, hyperglycemia was present at 13 and 20 wks of age and 9 corresponded with the declines in BMD observed during those time points (i.e., reduced 10
BMDs in the femoral necks, distal femora, proximal tibiae, and femoral and tibial mid-11 shafts of the ZDF rats). Furthermore, regression analysis demonstrated that plasma 12 glucose is negatively correlated with BMD ( Fig 6B) . Interestingly, neither 13 hyperglycemia nor bone loss were observed in the pre-diabetic (7 wks) fatty rats, but 14 rather, these animals often had greater BMDs vs. lean controls, further supporting the 15 temporal relation between hyperglycemia, AGEs accumulation, and enhanced skeletal 16 fragility with Type 2 diabetes. 17 formation following distraction osteogenesis in 9-11 week old ZDF rats that was 5 associated with hyperinsulinemia, hyperglycemia, attenuated serum osteocalcin levels 6 and leptin signaling deficiency. Thus, the leptin resistant status of ZDF rats indicates a 7 potential role for this factor in modulating bone mass. 8
In conclusion, the present study demonstrates diminished BMD and decrements in 9 a number of bone mechanical properties in the femora and tibiae with the progression of 10 Type 2 diabetes in the ZDF rat. The alterations in BMD and bone mechanical properties 11 were closely associated with the onset of hyperinsulinemia and hyperglycemia, which 12 may have direct adverse effects on skeletal tissue. Therefore, disparities in the human 13 literature regarding the effects of Type 2 diabetes on skeletal properties may be 14 associated with the bone sites studied and the severity or duration of the disease in the 15 patient population studied. We speculate that the chronic hyperglycemia may also have 16 resulted in altered structural and functional properties of the bone vascular network, 17 consequently resulting in diminished perfusion of the femora and tibiae. Type 2 diabetic fatty and lean control rats. White bars: Lean control rats (n = 10/ age 5 group); Black bars: Type 2 diabetic fatty rats (n = 9/ age group). Data represents mean ± 6 S.E. *Statistical differences from age-matched lean controls (p < 0.05). White bars: Lean control rats (n = 10/ age group); Black bars: Type 2 diabetic fatty rats 11 (n = 9/ age group). Data represents mean ± S.E. *Statistical differences from age-matched 12 lean controls (p < 0.05). †Denotes a tendency for statistical difference from age-matched 13 lean controls (p < 0.10). 14 15 values at yield, maximal and fracture forces from 3-point bending to failure tests for mid-22 shaft femur (A, C, E) and mid-shaft tibia (B, D, F) in Type 2 diabetic fatty rats and age-23 matched lean controls (refer to Table 2 for absolute values). 24 Values are mean ± S.E; n = 9-10/group. *Denotes significant differences from agematched lean controls (p < 0.05). Values are mean ± S.E; n = 9-10/group. *Denotes significant differences from agematched lean controls (p < 0.05). A.
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